The availability and accessibility of healthcare and molecular data continues to increase, with new sources emerging on a seemingly ongoing basis. Accessing data is only the first step to gaining valuable knowledge and insights. Powerful analytics are an essential component to deriving value from data assets. GNS is a leader in developing custom analytic solutions tailored to organizations’ specific needs to identify meaningful insights and optimize the value generated from this wealth of information.
GNS has partnered with many of the world’s largest and most innovative biopharmaceutical companies, foundations, academic medical centers, and health plans to create custom models that extract new information and value from health-related data.
In collaborations with its partners for the past 16 years, GNS has applied our causal machine learning platform, REFS, to 100+ projects that are applicable to all stages of the product development life-cycle to advance understanding of disease progression, drug response, and the commercialization of new products. The learnings derived from these projects have helped guide decisions that advance the entire value-chain of the pharmaceutical industry – from early-stage R&D through commercial operations.